This Stock Has Skyrocketed 125% in 2026 -- and Billionaire Stanley Druckenmiller Is Loading Up on It
Revolution Medicines could be a revolutionary biotech stock.
Overview
Revolution Medicines (NASDAQ: RVMD) aims to replace chemotherapy for some of the most aggressive cancers with its targeted treatments. It directly targets the RAS protein -- which feeds the growth of non-small cell lung, pancreatic, and colorectal cancers -- by shutting down the hyperactive cellular signals that drive their spread.
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.